Proposed Collection; 60-Day Comment Request; Generic Clearance for Surveys of Customers and Partners of the Office of Extramural Research of the National Institutes of Health, 10910-10911 [2017-03137]
Download as PDF
10910
Federal Register / Vol. 82, No. 31 / Thursday, February 16, 2017 / Notices
OS specifically requests comments on
(1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Terry S. Clark,
Asst. Information Collection Clearance
Officer.
Dated: February 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03087 Filed 2–15–17; 8:45 am]
[FR Doc. 2017–03080 Filed 2–15–17; 8:45 am]
BILLING CODE 4150–45–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; eCigaretts—from 3rd Award (8923).
Date: March 30, 2017.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 827–5702, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; eCigaretts—from 3rd Award (8925).
Date: March 30, 2017.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
VerDate Sep<11>2014
19:05 Feb 15, 2017
Jkt 241001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR 13–
374: Modeling Social Behavior.
Date: March 1, 2017.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Health Disparities in and Caregiving for
Alzheimer’s Disease.
Date: March 3, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Contact Person: Gabriel B Fosu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
MSC 7808, Bethesda, MD 20892, (301) 435–
3562, fosug@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: March 9, 2017.
Time: 11:59 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Preclinical Research on Model Organisms to
Predict Treatment Outcomes for Disorders
Associated with Intellectual and
Developmental Disabilities.
Date: March 13, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Biao Tian, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3089B, MSC 7848, Bethesda,
MD 20892, (301) 402–4411, tianbi@
csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 10, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–03079 Filed 2–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Generic Clearance for
Surveys of Customers and Partners of
the Office of Extramural Research of
the National Institutes of Health
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
SUMMARY:
E:\FR\FM\16FEN1.SGM
16FEN1
10911
Federal Register / Vol. 82, No. 31 / Thursday, February 16, 2017 / Notices
opportunity for public comment on
proposed data collection projects, the
Office of Extramural Research (OER),
the National Institutes of Health (NIH)
will publish periodic summaries of
propose projects to be submitted to the
Office of Management and Budget
(OMB) for review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Dr. Sherry Mills, Director,
Office of Extramural Programs, OER,
NIH, 6705 Rockledge Drive, Suite 350,
Bethesda, MD 20892, or call non-tollfree number (301) 435–2729, or Email
your request, including your address to:
OEPMailbox@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
forward with our initiatives to ensure
success in accomplishing the NIH
mission, input from partners and
customers is essential. Quality
management principles have been
integrated into OER’s culture and these
surveys will provide customer
satisfaction input on various elements of
OER’s business processes. The
approximately 14 (10 quantitative and 4
qualitative) customer satisfaction
surveys that will be conducted under
this generic clearance will gather and
measure customer and partner
satisfaction with OER processes and
operations. The data collected from
these surveys will provide the feedback
to track and gauge satisfaction with the
NIH’s statutorily mandated operations
and processes. OER/OD/NIH will
present data and outcomes from these
surveys to inform the NIH staff, officers,
leadership, advisory committees, and
other decision-making bodies as
appropriate. Based on feedback from
these stakeholders, OER/OD/NIH will
formulate improvement plans and take
action when necessary.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1911.
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title: Generic
Clearance for Surveys of Customers and
Partners of the Office of Extramural
Research of the National Institutes of
Health—Extension of 0925–0627—
Office of the Director (OD), Office of
Extramural Research (OER), Office of
Extramural Programs (OEP), National
Institutes of Health (NIH).
Need and Use of Information
Collection: OER develops, coordinates
the implementation of, and evaluates
NIH-wide policies and procedures for
the award of extramural funds. To move
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hour
Quantitative Survey
Science professionals, applicants, reviewers, Institutional Officials ................
Adult Science Trainees ....................................................................................
General Public .................................................................................................
1,500
1,000
2,500
1
1
1
20/60
20/60
20/60
500
333
833
200
25
20
1
1
1
1
1
1
200
25
20
Qualitative Survey
Science professionals, applicants, reviewers, Institutional Officials ................
Adult Science Trainees ....................................................................................
General Public .................................................................................................
Dated: February 10, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2017–03137 Filed 2–15–17; 8:45 am]
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
BILLING CODE 4140–01–P
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
19:05 Feb 15, 2017
Jkt 241001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
Date: February 27, 2017.
Time: 12:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\16FEN1.SGM
16FEN1
Agencies
[Federal Register Volume 82, Number 31 (Thursday, February 16, 2017)]
[Notices]
[Pages 10910-10911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03137]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Generic Clearance
for Surveys of Customers and Partners of the Office of Extramural
Research of the National Institutes of Health
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide
[[Page 10911]]
opportunity for public comment on proposed data collection projects,
the Office of Extramural Research (OER), the National Institutes of
Health (NIH) will publish periodic summaries of propose projects to be
submitted to the Office of Management and Budget (OMB) for review and
approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Dr. Sherry
Mills, Director, Office of Extramural Programs, OER, NIH, 6705
Rockledge Drive, Suite 350, Bethesda, MD 20892, or call non-toll-free
number (301) 435-2729, or Email your request, including your address
to: OEPMailbox@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Generic Clearance for Surveys of
Customers and Partners of the Office of Extramural Research of the
National Institutes of Health--Extension of 0925-0627--Office of the
Director (OD), Office of Extramural Research (OER), Office of
Extramural Programs (OEP), National Institutes of Health (NIH).
Need and Use of Information Collection: OER develops, coordinates
the implementation of, and evaluates NIH-wide policies and procedures
for the award of extramural funds. To move forward with our initiatives
to ensure success in accomplishing the NIH mission, input from partners
and customers is essential. Quality management principles have been
integrated into OER's culture and these surveys will provide customer
satisfaction input on various elements of OER's business processes. The
approximately 14 (10 quantitative and 4 qualitative) customer
satisfaction surveys that will be conducted under this generic
clearance will gather and measure customer and partner satisfaction
with OER processes and operations. The data collected from these
surveys will provide the feedback to track and gauge satisfaction with
the NIH's statutorily mandated operations and processes. OER/OD/NIH
will present data and outcomes from these surveys to inform the NIH
staff, officers, leadership, advisory committees, and other decision-
making bodies as appropriate. Based on feedback from these
stakeholders, OER/OD/NIH will formulate improvement plans and take
action when necessary.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1911.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total annual
Type of respondent respondents responses per response (in burden hour
respondent hours)
----------------------------------------------------------------------------------------------------------------
Quantitative Survey
----------------------------------------------------------------------------------------------------------------
Science professionals, applicants, reviewers, 1,500 1 20/60 500
Institutional Officials........................
Adult Science Trainees.......................... 1,000 1 20/60 333
General Public.................................. 2,500 1 20/60 833
----------------------------------------------------------------------------------------------------------------
Qualitative Survey
----------------------------------------------------------------------------------------------------------------
Science professionals, applicants, reviewers, 200 1 1 200
Institutional Officials........................
Adult Science Trainees.......................... 25 1 1 25
General Public.................................. 20 1 1 20
----------------------------------------------------------------------------------------------------------------
Dated: February 10, 2017.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2017-03137 Filed 2-15-17; 8:45 am]
BILLING CODE 4140-01-P